 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/587511
Asia Pacific Markets for Peripheral Vascular Devices (Australia, China, India, South Korea, Taiwan, Rest of Asia Pacific)
|
Description: |
This market was valued at almost $145 million in 2006.
The Asia Pacific peripheral vascular device market consists of China, Australia, India, South Korea, Taiwan, and the Rest of Asia Pacific.
Get coverage on the peripheral vascular (PV) markets in China, Australia, India, South Korea, Taiwan, and the rest of Asia Pacific (Malaysia, Thailand, Singapore, Pakistan, Philippines, and Vietnam). Discover how China and Australia collectively composed over two-thirds of the Asia Pacific PV device market in 2006. See how aging populations in emerging markets and developed countries alike will be strong drivers of the PV market throughout the forecast. Learn how growth in emerging economies is affecting different segments of the Asia Pacific PV device market.
The following report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research. Secondary sources include:
Government Sources: - Securities and Exchange Commission filings - Food and Drug Administration and patent filings - National Center for Health Statistics data
Transcatheter Embolization and Occlusion Companies: - Annual reports, product brochures, corporate profiles, etc.
Internal Databases and Reports: - Previous reports on similar/related sources
General Internet Searches, Medical Literature and Newspaper/Magazine Searches: - Identifying various centers of specialization and articles that might provide leads for primary research. The secondary research stage builds the foundation for the primary research. The primary research methodology has four steps:
Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is, thus, either discarded or marked as high or low priority. It is then organized appropriately as determined by the structure and sectioning of the report.
Step 2: At this stage, early assumptions are formed as to the implications of the information for the various transcatheter embolization and occlusion market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes [units and US$] and market shares).
Step 3: At this stage, the research is in position for it’s most important primary phase — expert interviews. Throughout the secondary research, industry and medical experts are identified. These experts are now contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of the particular interviewee, although in most cases, the most important questions are asked of all experts. The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then either augmented, discarded, or adjusted, based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and reach positions of consensus on issues and market numbers.
Step 4: The final stage of primary research involves individual and group analysis. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.
Forecast Methodology
In addition to Steps 1 through 4 (as outlined above), the following “bottom-up” methodology was followed in developing forecast assumptions for this report. A comprehensive breakdown of various transcatheter embolization and occlusion procedures was prepared using data from several sources including professional associations, government statistics, and private research/media sources. Industry experts and practitioners were consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through 10Ks and other sources were compared against modeled industry revenues.
Using the best estimates of industry experts, practitioners, private research/media sources, and in-house experts, year-by-year growth rates and average selling prices were applied individually to each subcategory to derive forecasts. These estimates were cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined. Overall findings were compared against market and procedure forecasts published by other sources to ensure reasonable estimates. |
|
Contents: |
TABLE OF CONTENTS LIST OF EXHIBITS EXECUTIVE SUMMARY METHODOLOGY
1.0 ASIA PACIFIC PERIPHERAL VASCULAR DEVICE MARKET 1.1 Market Overview 1.1.2 Asia Pacific Healthcare Overview 1.1.2.1 China 1.1.2.2 Australia 1.1.2.3 India 1.1.2.4 South Korea 1.1.2.5 Taiwan 1.1.2.6 Rest of Asia Pacific 1.1.3 Peripheral Vascular Treatment Overview 1.1.3.1 Carotid 1.1.3.2 Aorta 1.1.3.3 Renal 1.1.3.4 Iliac 1.1.3.5 Lower Extremities 1.1.3.6 Inferior Vena Cava 1.1.3.7 Arteriovenous Access 1.2 Market Analysis 1.2.1 Market Forecast 1.2.1.1 China 1.2.1.2 Australia 1.2.1.3 India 1.2.1.4 South Korea 1.2.1.5 Taiwan 1.2.1.6 Rest of Asia Pacific 1.2.2 Market Drivers and Limiters 1.3 Competitive Analysis
2.0 PERIPHERAL VASCULAR STENT MARKET 2.1 Market Overview 2.1.1 China 2.1.2 Australia 2.1.3 India 2.1.4 South Korea 2.1.5 Taiwan 2.1.6 Rest of Asia Pacific 2.2 Market Analysis 2.2.1 Procedures 2.2.1.1 Carotid 2.2.1.2 Renal 2.2.1.3 Iliac 2.2.1.4 Femoral-popliteal 2.2.1.5 Infrapopliteal 2.2.2 Market Forecast 2.2.2.1 Carotid Stent Market 2.2.2.2 Renal Stent Market 2.2.2.3 Iliac Stent Market 2.2.2.4 Femoral-popliteal Stent Market 2.2.2.5 Infrapopliteal Stent Market 2.2.3 Market Drivers and Limiters 2.3 Competitive Analysis
3.0 PTA BALLOON MARKET 3.1 Market Overview 3.1.1 China 3.1.2 Australia 3.1.3 India 3.1.4 South Korea 3.1.5 Taiwan 3.1.6 Rest of Asia Pacific 3.2 Market Analysis 3.2.1 Procedures 3.2.1.1 Carotid 3.2.1.2 Renal 3.2.1.3 Iliac 3.2.1.4 Femoral-popliteal 3.2.1.5 Infrapopliteal 3.2.1.6 Endovascular Aortic Repair 3.2.1.7 Arteriovenous Access 3.2.2 Market Forecast 3.2.2.1 PTA Balloon Reuse Analysis 3.2.2.2 Standard PTA Balloon Market 3.2.2.3 Small PTA Balloon Market 3.2.2.4 Other PTA Balloon Market 3.2.3 Market Drivers and Limiters 3.3 Competitive Analysis
4.0 EMBOLIC PROTECTION DEVICE MARKET 4.1 Market Overview 4.1.1 China 4.1.2 Australia 4.1.3 India 4.1.4 South Korea 4.1.5 Taiwan 4.1.6 Rest of Asia Pacific 4.2 Market Analysis 4.2.1 Procedures 4.2.2 Market Forecast 4.2.3 Market Drivers and Limiters 4.3 Competitive Analysis
5.0 INFERIOR VENA CAVA FILTER MARKET 5.1 Market Overview 5.1.1 China 5.1.2 Australia 5.1.3 India 5.1.4 South Korea 5.1.5 Taiwan 5.1.6 Rest of Asia Pacific 5.2 Market Analysis 5.2.1 Procedures 5.2.1.1 Filter Retrieval 5.2.2 Market Forecast 5.2.3 Market Drivers and Limiters 5.3 Competitive Analysis
6.0 AORTIC STENT GRAFT MARKET 6.1 Market Overview 6.1.1 China 6.1.2 Australia 6.1.3 India 6.1.4 South Korea 6.1.5 Taiwan 6.1.6 Rest of Asia Pacific 6.2 Market Analysis 6.2.1 Procedures 6.2.1.1 Abdominal Aorta Procedures 6.2.1.2 Thoracic Aorta Procedures 6.2.2 Market Forecast 6.2.2.1 Abdominal Aortic Stent Graft Market 6.2.2.2 Thoracic Aortic Stent Graft Market 6.2.3 Market Drivers and Limiters 6.3 Competitive Analysis
7.0 SYNTHETIC SURGICAL GRAFT MARKET 7.1 Market Overview 7.1.1 China 7.1.2 Australia 7.1.3 India 7.1.4 South Korea 7.1.5 Taiwan 7.1.6 Rest of Asia Pacific 7.2 Market Analysis 7.2.1 Procedures 7.2.1.1 Peripheral Bypass 7.2.1.2 Arteriovenous Access 7.2.1.3 Abdominal Aortic Aneurysms 7.2.1.4 Extra-Anatomical Bypass 7.2.1.5 Thoracic Aorta 7.2.2 Market Forecast 7.2.2.1 Peripheral Bypass Graft Market 7.2.2.2 Arteriovenous Access Graft Market 7.2.2.3 Abdominal Aortic Aneurysm Graft Market 7.2.2.4 Extra-Anatomical Bypass Graft Market 7.2.2.5 Thoracic Aortic Graft Market 7.2.3 Market Drivers and Limiters 7.3 Competitive Analysis
8.0 PERIPHERAL VASCULAR ACCESSORY DEVICE MARKET 8.1 Market Overview 8.1.1 China 8.1.2 Australia 8.1.3 India 8.1.4 South Korea 8.1.5 Taiwan 8.1.6 Rest of Asia Pacific 8.2 Market Analysis 8.2.1 Procedures 8.2.1.1 Diagnostic Procedures 8.2.1.2 Interventional Procedures 8.2.2 Market Forecast 8.2.2.1 Peripheral Vascular Accessory Device Reuse Analysis 8.2.2.2 Peripheral Guidewire Market 8.2.2.3 Diagnostic Catheter Market 8.2.2.4 Introducer Sheath Market 8.2.3 Market Drivers and Limiters 8.3 Competitive Analysis APPENDIX A: MRG ACRONYMS AND INITIALISMS List of Exhibits:ts EXECUTIVE SUMMARY Exhibit ES-1: PV Device Market, by Device, as a % of Total, Asia Pacific, 2006 Exhibit ES-2: PV Device Market, by Device, Asia Pacific (US$), 2005–2011 Exhibit ES-3: PV Stent Procedures, by Indication, Asia Pacific, 2005–2011 Exhibit ES-4: PTA Balloon Procedures, by Indication, as a % of Total, Asia Pacific, 2005–2011 Exhibit ES-5: EPD Market, China versus Others, Asia Pacific (US$), 2005– 2011 Exhibit ES-6: IVCF Procedures, by Device Type, Asia Pacific, 2005–2011 Exhibit ES-7: EVAR Penetration into Aortic Graft Procedures, by Type, Asia Pacific, 2005–2011 Exhibit ES-8: Synthetic Surgical Graft Market, by Indication, as a % of Total, Asia Pacific, 2006 Exhibit ES-9: Accessory Device Market, by Device Type, Asia Pacific (US$), 2005–2011 Exhibit ES-10: Leading Competitors in the PV Device Market, Asia Pacific, 2006
CHAPTER 1: ASIA PACIFIC PERIPHERAL VASCULAR DEVICE MARKET Exhibit 1-1: PV Device Market, Asia Pacific (US$), 2005–2011 Exhibit 1-2: PV Device Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 1-3: PV Device Market, by Country, as a % of Total, Asia Pacific, 2006 and 2011 Exhibit 1-4: Health Statistics and Regulatory Information, China Exhibit 1-5: Population Demographics, by Age Group, as a % of Total, China, 2005–2025 [Graphical Format] Exhibit 1-6: Population Demographics, by Age Group, as a % of Total, China, 2005–2025 [Tabular Format] Exhibit 1-7: Health Statistics and Regulatory Information, Australia Exhibit 1-8: Population Demographics, by Age Group, as a % of Total, Australia, 2005–2025 [Graphical Format] Exhibit 1-9: Population Demographics, by Age Group, as a % of Total, Australia, 2005–2025 [Tabular Format] Exhibit 1-10: Health Statistics and Regulatory Information, India Exhibit 1-11: Population Demographics, by Age Group, as a % of Total, India, 2005–2025 [Graphical Format] Exhibit 1-12: Population Demographics, by Age Group, as a % of Total, India, 2005–2025 [Tabular Format] Exhibit 1-13: Health Statistics and Regulatory Information, South Korea Exhibit 1-14: Population Demographics, by Age Group, as a % of Total, South Korea, 2005–2025 [Graphical Format] Exhibit 1-15: Population Demographics, by Age Group, as a % of Total, South Korea, 2005–2025 [Tabular Format] Exhibit 1-16: Health Statistics and Regulatory Information, Taiwan Exhibit 1-17: Population Demographics, by Age Group, as a % of Total, Taiwan, 2006–2026 [Graphical Format] Exhibit 1-18: Population Demographics, by Age Group, as a % of Total, Taiwan, 2006–2025 [Tabular Format] Exhibit 1-19: Population Demographics, by Age Group, as a % of Total, ROAP, 2005–2025 [Graphical Format] Exhibit 1-20: Population Demographics, by Age Group, as a % of Total, ROAP, 2005–2025 [Tabular Format] Exhibit 1-21: PV Interventional Procedures, by Type and Country, Asia Pacific, 2005–2011 Exhibit 1-22: EPD Types Exhibit 1-23: EPD Types (Continued) Exhibit 1-24: Rupture Risk of Untreated AAA Exhibit 1-25: Vena Cava Filter Indications Exhibit 1-26: PV Device Market, by Device, Asia Pacific (US$), 2005–2011 Exhibit 1-27: PV Device Market, by Device and Country, as a % of Total, Asia Pacific, 2006 [Graphical Format] Exhibit 1-28: PV Device Market, by Device and Country, as a % of Total, Asia Pacific, 2006 [Tabular Format] Exhibit 1-29: PV Device Market, by Device, China (US$), 2005–2011 [Graphical Format] Exhibit 1-30: PV Device Market, by Device, China (US$), 2005–2011 [Tabular Format] Exhibit 1-31: PV Device Market, by Device, Australia (US$), 2005–2011 [Graphical Format] Exhibit 1-32: PV Device Market, by Device, Australia (US$), 2005–2011 [Tabular Format] Exhibit 1-33: PV Device Market, by Device, India (US$), 2005–2011 [Graphical Format] Exhibit 1-34: PV Device Market, by Device, India (US$), 2005–2011 [Tabular Format] Exhibit 1-35: PV Device Market, by Device, South Korea (US$), 2005–2011 [Graphical Format] Exhibit 1-36: PV Device Market, by Device, South Korea (US$), 2005–2011 [Tabular Format] Exhibit 1-37: PV Device Market, by Device, Taiwan (US$), 2005–2011 [Graphical Format] Exhibit 1-38: PV Device Market, by Device, Taiwan (US$), 2005–2011 [Tabular Format] Exhibit 1-39: PV Device Market, by Device, ROAP (US$), 2005–2011 [Graphical Format] Exhibit 1-40: PV Device Market, by Device, ROAP (US$), 2005–2011 [Tabular Format] Exhibit 1-41: Drivers of the PV Device Market, Asia Pacific Exhibit 1-42: Drivers of the PV Device Market, Asia Pacific (Continued) Exhibit 1-43: Limiters of the PV Device Market, Asia Pacific Exhibit 1-44: Limiters of the PV Device Market, Asia Pacific (Continued) Exhibit 1-45: Leading Competitors in the PV Device Market, by Device, Asia Pacific, 2006 Exhibit 1-46: Leading Competitors in the PV Device Market, by Country, Asia Pacific, 2006
CHAPTER 2: PERIPHERAL VASCULAR STENT MARKET Exhibit 2-1: PV Stent Market, Asia Pacific (US$), 2005–2011 Exhibit 2-2: PV Stent Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 2-3: PV Stent Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 2-4: PV Stent Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 2-5: PV Stent Procedures, by Indication, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 2-6: PV Stent Procedures, by Indication, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 2-7: Carotid Stenting Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 2-8: Renal Stenting Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 2-9: Iliac Stenting Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 2-10: Fem-pop Stenting Procedures, by Country, Asia Pacific, 2005– 2011 Exhibit 2-11: Infrapop Stenting Procedures, by Country, Asia Pacific, 2005– 2011 Exhibit 2-12: PV Stent Revenues, by Indication, Asia Pacific (US$), 2005–2011 Exhibit 2-13: PV Stent Units, by Indication, Asia Pacific, 2005–2011 Exhibit 2-14: PV Stent Market, by Indication, Asia Pacific (US$), 2005–2011 Exhibit 2-15: PV Stent Market Growth, by Indication, Asia Pacific, 2006–2011 Exhibit 2-16: PV Stent Market, by Indication, as a % of Total, Asia Pacific, 2005–2011 Exhibit 2-17: Carotid Stent Units, by Country, Asia Pacific, 2005–2011 Exhibit 2-18: Carotid Stent Market, by Country, Asia Pacific (US$), 2005–2011 105 Exhibit 2-19: Carotid Stent Market Growth, by Country, Asia Pacific, 2006– 2011 Exhibit 2-20: Carotid Stent Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 2-21: Renal Stent Units, by Country, Asia Pacific, 2005–2011 Exhibit 2-22: Renal Stent Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 2-23: Renal Stent Market Growth, by Country, Asia Pacific, 2006– 2011 Exhibit 2-24: Renal Stent Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 2-25: Iliac Stent Units, by Country, Asia Pacific, 2005–2011 Exhibit 2-26: Iliac Stent Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 2-27: Iliac Stent Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 2-28: Iliac Stent Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 2-29: Fem-pop Stent Units, by Country, Asia Pacific, 2005–2011 Exhibit 2-30: Fem-pop Stent Market, by Country, Asia Pacific (US$), 2005– 2011 Exhibit 2-31: Fem-pop Stent Market Growth, by Country, Asia Pacific, 2006– 2011 1 Exhibit 2-32: Fem-pop Stent Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 2-33: Infrapop Stent Units, by Country, Asia Pacific, 2005–2011 Exhibit 2-34: Infrapop Stent Market, by Country, Asia Pacific (US$), 2005– 2011 Exhibit 2-35: Infrapop Stent Market Growth, by Country, Asia Pacific, 2006– 2011 Exhibit 2-36: Infrapop Stent Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 2-37: Drivers of the PV Stent Market, Asia Pacific Exhibit 2-38: Limiters of the PV Stent Market, Asia Pacific Exhibit 2-39: Leading Competitors in the PV Stent Market, by Country, Asia Pacific, 2006
CHAPTER 3: PERCUTANEOUS TRANSLUMINAL ANGIOSPLASTY BALLOON MARKET Exhibit 3-1: PTA Balloon Market, Asia Pacific (US$), 2005–2011 Exhibit 3-2: PTA Balloon Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 3-3: PTA Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 3-4: PTA Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 3-5: Treatment Indications, by PTA Balloon Type Exhibit 3-6: PTA Procedures, by Indication, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 3-7: PTA Procedures, by Indication, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 3-8: PTA Procedures, by Balloon Type, Asia Pacific, 2005–2011 Exhibit 3-9: PTA Procedures, by Balloon Type and Indication, as a % of Total, Asia Pacific, 2006 1 Exhibit 3-10: Carotid PTA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 3-11: Renal PTA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 3-12: Iliac PTA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 3-13: Fem-pop PTA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 3-14: Infrapop PTA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 3-15: EVAR PTA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 3-16: AV PTA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 3-17: PTA Balloon Revenues, by Balloon Type, Asia Pacific (US$), 2005–2011 Exhibit 3-18: PTA Balloon Units, by Balloon Type, Asia Pacific, 2005–2011 Exhibit 3-19: PTA Balloon Market, by Balloon Type, Asia Pacific (US$), 2005– 2011 Exhibit 3-20: PTA Balloon Market Growth, by Balloon Type, Asia Pacific, 2006–2011 Exhibit 3-21: PTA Balloon Reuse Analysis, by Country, 2006 Exhibit 3-22: Standard PTA Balloon Units, by Country, Asia Pacific, 2005– 2011 Exhibit 3-23: Standard PTA Balloon Market, by Country (US$), Asia Pacific, 2005–2011 Exhibit 3-24: Standard PTA Balloon Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 3-25: Small PTA Balloon Units, by Country, Asia Pacific, 2005–2011 Exhibit 3-26: Small PTA Balloon Market, by Country (US$), Asia Pacific, 2005– 2011 Exhibit 3-27: Small PTA Balloon Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 3-28: Other PTA Balloon Units, by Country, Asia Pacific, 2005–2011 Exhibit 3-29: Other PTA Balloon Market, by Country (US$), Asia Pacific, 2005– 2011 Exhibit 3-30: Other PTA Balloon Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 3-31: Drivers of the PTA Balloon Market, Asia Pacific Exhibit 3-32: Limiters of the PTA Balloon Market, Asia Pacific Exhibit 3-33: Leading Competitors in the PTA Balloon Market, by Country, Asia Pacific, 2006
CHAPTER 4: EMBOLIC PROTECTION DEVICE MARKET Exhibit 4-1: EPD Market, Asia Pacific (US$), 2005–2011 Exhibit 4-2: EPD Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 4-3: CAS Procedures and Carotid EPD Penetration, Asia Pacific, 2005– 2011 Exhibit 4-4: Carotid EPD Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 4-5: Carotid EPD Procedure Growth, by Country, Asia Pacific, 2006– 2011 Exhibit 4-6: EPD Revenues, by Country, Asia Pacific (US$), 2005–2011 Exhibit 4-7: EPD Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 4-8: EPD Market Growth, by Country , Asia Pacific, 2006–2011 Exhibit 4-9: Drivers of the EPD Market, Asia Pacific Exhibit 4-10: Limiters of the EPD Market, Asia Pacific Exhibit 4-11: Leading Competitors in the EPD Market, by Country, Asia Pacific, 2006
CHAPTER 5: INFERIOR VENA CAVA FILTER MARKET Exhibit 5-1: IVCF Market, Asia Pacific (US$), 2005–2011 Exhibit 5-2: IVCF Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 5-3: IVCF Placement Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 5-4: IVCF Placement Procedures, by Device Type and Country, Asia Pacific, 2005–2011 Exhibit 5-5: IVCF Placement Procedure Growth, by Device Type and Country, Asia Pacific, 2006–2011 Exhibit 5-6: IVCF Retrieval Rates, by Country, Asia Pacific, 2005–2011 Exhibit 5-7: IVCF Procedures, by Device Type, Asia Pacific (US$), 2005–2011 Exhibit 5-8: IVCF Market, by Device Type, Asia Pacific (US$), 2005–2011 Exhibit 5-9: Retrievable IVCF Market, by Country, Asia Pacific (US$), 2005– 2011 Exhibit 5-10: Retrievable IVCF Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 5-11: Permanent IVCF Market, by Country, Asia Pacific (US$), 2005– 2011 Exhibit 5-12: Permanent IVCF Market Growth, by Country, Asia Pacific, 2006– 2011 Exhibit 5-13: Drivers of the IVCF Market, Asia Pacific Exhibit 5-14: Limiters of the IVCF Market, Asia Pacific Exhibit 5-15: Leading Competitors in the IVCF Market, by Country, Asia Pacific, 2006
CHAPTER 6: AORTIC STENT GRAFT MARKET Exhibit 6-1: Aortic Stent Graft Market, Asia Pacific (US$), 2005–2011 Exhibit 6-2: Aortic Stent Graft Market, by Country, Asia Pacific (US$), 2005– 2011 Exhibit 6-3: Aortic Stent Graft Procedures, by Country, Asia Pacific, 2005– 2011 [Graphical Format] Exhibit 6-4: Aortic Stent Graft Procedures, by Country, Asia Pacific, 2005– 2011 [Tabular Format] Exhibit 6-5: Aortic Stent Graft Procedures, by Indication, Asia Pacific, 2005– 2011(Graphical Format) Exhibit 6-6: Aortic Stent Graft Procedures, by Indication, Asia Pacific, 2005– 2011(Tabular Format) Exhibit 6-7: AAA Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 6-8: AAA Procedure Growth, by Country and Procedure Type, Asia Pacific, 2006–2011 Exhibit 6-9: Thoracic Aortic Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 6-10: Thoracic Aortic Procedure Growth, by Country and Procedure Type, Asia Pacific, 2006–2011 Exhibit 6-11: Thoracic Aortic Procedures, by Country and Indication, as a % of Total, Asia Pacific, 2006-2011 Exhibit 6-12: Aortic Stent Graft Revenues and Growth, by Indication, Asia Pacific (US$), 2005–2011 Exhibit 6-13: Aortic Stent Graft Market, by Indication, Asia Pacific (US$), 2005–2011 Exhibit 6-14: AAA Stent Graft Market, by Country, Asia Pacific (US$), 2005– 2011 Exhibit 6-15: AAA Stent Graft Market Growth, by Country, Asia Pacific, 2006– 2011 Exhibit 6-16: Thoracic Aortic Stent Graft Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 6-17: Thoracic Aortic Stent Graft Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 6-18: Drivers of the Aortic Stent Graft Market, Asia Pacific Exhibit 6-19: Limiters of the Aortic Stent Graft Market, Asia Pacific Exhibit 6-20: Leading Competitors in the Aortic Stent Graft Market, by Country, Asia Pacific, 2006
CHAPTER 7: SYNTHETIC SURGICAL GRAFT MARKET Exhibit 7-1: Synthetic Surgical Graft Market, Asia Pacific (US$), 2005–2011 Exhibit 7-2: Synthetic Surgical Graft Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 7-3: Synthetic Surgical Graft Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 7-4: Synthetic Surgical Graft Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 7-5: Synthetic Surgical Graft Procedures, by Indication, Asia Pacific, 2005–2011 Exhibit 7-6: PB Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 7-7: PB Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 7-8: AV Access Graft Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 7-9: AV Access Graft Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 7-10: AAA Graft Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 7-11: AAA Graft Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 7-12: XA Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 7-13: XA Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 7-14: Thoracic Aortic Graft Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 7-15: Thoracic Aortic Graft Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 7-16: Synthetic Surgical Graft Market, by Indication, Asia Pacific (US$), 2005–2011 [Graphical Format] Exhibit 7-17: Synthetic Surgical Graft Market, by Indication, Asia Pacific (US$), 2005–2011 [Tabular Format] Exhibit 7-18: Synthetic Surgical Graft Market Growth, by Indication, Asia Pacific, 2006–2011 Exhibit 7-19: Synthetic Surgical Graft Market, by Indication, as a % of Total, Asia Pacific, 2005–2011 Exhibit 7-20: PB Graft Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 7-21: PB Graft Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 7-22: PB Graft Market, by Country, as a % of Total, Asia Pacific, 2005– 2011 Exhibit 7-23: AV Access Graft Market, by Country, Asia Pacific (US$), 2005– 2011 Exhibit 7-24: AV Access Graft Market Growth, by Country, Asia Pacific, 2006– 2011 Exhibit 7-25: AV Access Graft Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 7-26: AAA Graft Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 7-27: AAA Graft Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 7-28: AAA Graft Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 7-29: XA Graft Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 7-30: XA Graft Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 7-31: XA Graft Market, by Country, as a % of Total, Asia Pacific, 2005– 2011 Exhibit 7-32: Thoracic Aortic Graft Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 7-33: Thoracic Aortic Graft Market Growth, by Country, Asia Pacific, 2006–2011 Exhibit 7-34: Thoracic Aortic Graft Market, by Country, as a % of Total, Asia Pacific, 2005–2011 Exhibit 7-35: Drivers of the Synthetic Surgical Graft Market, Asia Pacific Exhibit 7-36: Limiters of the Synthetic Surgical Graft Market, Asia Pacific Exhibit 7-37: Leading Competitors in the Synthetic Surgical Graft Market, by Country, Asia Pacific, 2006
CHAPTER 8: PERIPHERAL VASCULAR ACCESSORY DEVICE MARKET Exhibit 8-1: PV Accessory Device Market, Asia Pacific (US$), 2005–2011 Exhibit 8-2: PV Accessory Device Market, by Country, Asia Pacific (US$), 2005–2011 Exhibit 8-3: Peripheral Endovascular Procedures, by Country, Asia Pacific, 2005–2011 [Graphical Format] Exhibit 8-4: Peripheral Endovascular Procedures, by Country, Asia Pacific, 2005–2011 [Tabular Format] Exhibit 8-5: Peripheral Endovascular Procedures, by Procedure Type, Asia Pacific, 2005–2011 Exhibit 8-6: PV Diagnostic Procedures, by Country, Asia Pacific, 2005–2011 Exhibit 8-7: PV Interventional Procedures, by Country, Asia Pacific, 2005– 2011 Exhibit 8-8: PV Accessory Device Market, by Device Type (US$), Asia Pacific, 2005–2011 Exhibit 8-9: PV Accessory Device Market Growth, by Device Type, Asia Pacific, 2006–2011 Exhibit 8-10: Peripheral Vascular Accessory Device Reuse Analysis, by Country, 2006 |
|
Companies Mentioned |
Atrium Medical
Cordis
Microport
B. Braun
C.R. Bard
Opti-Med
Biotronik
Edwards Lifesciences
Terumo
Boston Scientific
ev3
W.L. Gore
Cook
Medtronic
... and many more! |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/587511
Order by Fax - using the order form below
Order By Post - print the order form below and send to
 |
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2 Printed 12/10/2008 11:04:03 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
Product Name: |
Asia Pacific Markets for Peripheral Vascular Devices (Australia, China, India, South Korea, Taiwan, Rest of Asia Pacific)
|
|
Web Address: |
http://www.researchandmarkets.com/reports/587511
|
|
Office Code: |
|
OCHKFJOPNXT
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Hard Copy
|
|
€7,527.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic (PDF)
- Single User
|
|
€8,020.00
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
 |
|
First Name: |
Last Name: |
|
Email Address: |
 |
|
Job Title: |
 |
|
Organisation: |
 |
|
Address: |
 |
|
City: |
 |
|
Postal/Zip Code: |
 |
|
Country: |
 |
|
Phone Number: |
 |
|
Fax Number: |
 |
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
 |
Page 2 of 2 Printed 12/10/2008 11:04:03
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
American Express
|
|
Diners Club
|
|
Master Card
|
|
Visa
|
|
|
|
 |
|
Cardholder Name: |
 |
|
|
|
Expiry Date: |
/  |
|
|
|
Card Number: |
 |
|
|
|
CVV Security Code: |
 |
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
 |
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
 |
|
 |
Please transfer funds to:
 |
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
 |
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353 1 481 1716 or +353 1 653 1571 - From Rest of World
|
 |
 |
|
|